Yu-Rong Hu
Overview
Explore the profile of Yu-Rong Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Lin H, Lo C
Macromol Rapid Commun
. 2024 Nov;
46(3):e2400731.
PMID: 39556693
This study investigates the crystallization behavior of electrospun coaxial fibers composed of crystalline poly(ethylene oxide) (PEO) in the core and crystalline poly(L-lactide) (PLLA) in the sheath. The influence of cold...
2.
Hu Y, Chen Y, Liu Y
Sheng Li Xue Bao
. 2021 Mar;
73(1):115-125.
PMID: 33665666
In eukaryotic cells, the endoplasmic reticulum (ER) is the key quality control organelle for cellular protein synthesis and processing. It also serves as an important site for Ca storage and...
3.
Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs /PEI/miRNA/ HA Nanocomplexes
Yan L, Guo X, Wang W, Hu Y, Duan S, Liu Y, et al.
Curr Cancer Drug Targets
. 2018 Oct;
19(4):330-337.
PMID: 30332960
Background: MicroRNA (miRNA) therapy, which was widely considered to treat a series of cancer, has been confronted with numerous obstacles to being delivered into target cells because of its easy...
4.
Qiao H, Hu Y, Tian X, Jia L, Gao N, Zhang L, et al.
Eur J Clin Pharmacol
. 2006 Jan;
62(2):107-12.
PMID: 16402242
Objective: Omeprazole, lansoprazole and rabeprazole have been widely used as proton pump inhibitors (PPIs). They can be metabolized in the liver by CYP2C19, a polymorphic enzyme, and have a wide...
5.
Hu Y, Qiao H, Kan Q
Acta Pharmacol Sin
. 2004 Aug;
25(8):986-90.
PMID: 15301728
Aim: To study the kinetic characteristics of lansoprazole in healthy Chinese subjects in relation to CYP2C19 genotype status for the individualized dose regimen of lansoprazole. Methods: Nine homozygous extensive metabolizers...